Diagnostic significance of serum FGD5-AS1 and its predictive value for the development of cardiovascular diseases in patients with type 2 diabetes

• Published in: Diabetology and metabolic syndrome Vol. 14; no. 1; p. 20
• Main Authors: Wang, Yongdi, Wang, Jian
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 28-01-2022; BioMed Central; BMC
• Subjects: Analysis; Apoptosis; Biomarkers; Blood pressure; Blood sugar; Calcification; Cardiovascular complications; Cardiovascular disease; Cardiovascular diseases; Care and treatment; Cholesterol; Complications and side effects; Correlation analysis; Development and progression; Diabetes; Diabetes mellitus (non-insulin dependent); FGD5-AS1; Fibrosis; Gene expression; Glucose; Glycosylated hemoglobin; High density lipoprotein; Insulin; Medical diagnosis; Medical research; Medicine, Experimental; Metabolism; Mortality; Phosphatase; Triglycerides; Type 2 diabetes; Type 2 diabetes mellitus; China; Taiwan; United States > US; FGD5-AS1; Type 2 diabetes mellitus; Cardiovascular complications
• ISSN: 1758-5996; 1758-5996
• DOI: 10.1186/s13098-022-00789-x

As a result of the continuous rise in the incidence of type 2 diabetes mellitus (T2DM), related cardiovascular diseases (CVDs) have been a main healthy burden worldwide. This study aimed to investigate the potential role of FGD5-AS1 as a biomarker for the diagnosis of T2DM and predicting cardiovascular complications in T2DM.
Three hundred subjects were recruited in this study, including 100 T2DM patients without CVDs, 100 T2DM patients with CVDs as well as 100 healthy subjects. Plasma FGD5-AS1 level was quantified using RT-qPCR assay. The correlation of FGD5-AS1 level with other key variables was assessed using Pearson correlation analysis. ROC curve analysis was performed to evaluate the diagnostic value of FGD5-AS1 for T2DM and related CVDs. The effect of FGD5-AS1 on AC16 and HA-VSMCs was determined.
FGD5-AS1 level showed a stepwise decrease in individuals with T2DM and CVDs compared to healthy persons. FGD5-AS1 was associated with BMI, systolic blood pressure, diastolic blood pressure, fasting glucose, 2-h postprandial blood glucose, HbA1c, triglycerides, usCRP, and HDL-cholesterol. The ROC analysis indicated FGD5-AS1 had a significant overall predictive ability to diagnose T2DM, T2DM with CVDs, and the combination of both. FGD5-AS1 increases the growth but alleviates apoptosis and fibrosis of high glucose-induced AC16 cells. FGD5-AS1 attenuate the growth and calcification but induced apoptosis of high glucose-treated HA-VSMC cells.
These results suggest that FGD5-AS1 are associated with T2DM and measuring FGD5-AS1 could potentially contribute to T2DM screening and prediction for risk of cardiovascular complication.